Sign in

CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471144582
Phone
781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,050,832
in 7 filings, $404K under 10b5-1 plans

Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 79 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-01 Ticho Barry CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −5,504 80,442
2024-02-13 TZIANABOS ARTHUR Director Option exercise +31,739 $2.19 $70K 31,739
2024-02-13 TZIANABOS ARTHUR Director Option exercise · Stock Option (Right to Buy) −31,739 0
2024-02-01 Ticho Barry CHIEF MEDICAL OFFICER Sale 10b5-1 −10,000 $4.80 $48K 6,981
2024-01-02 Ticho Barry Chief Medical Officer Sale 10b5-1 −10,000 $5.74 $57K 16,981
2023-12-01 Tulipano Stephen J CFO Returned to the company · Employee Stock Option (Right to Buy) −60,000 0
2023-12-01 Tulipano Stephen J CFO Returned to the company · Employee Stock Option (Right to Buy) −65,600 0
2023-12-01 Tulipano Stephen J CFO Returned to the company · Employee Stock Option (Right to Buy) −107,400 0
2023-12-01 Tulipano Stephen J CFO Grant or award · Restricted Stock Unit (RSU) +60,773 60,773
2023-12-01 Ticho Barry Chief Medical Officer Returned to the company · Employee Stock Option (Right to Buy) −60,000 0
2023-12-01 Ticho Barry Chief Medical Officer Returned to the company · Employee Stock Option (Right to Buy) −65,600 0
2023-12-01 Ticho Barry Chief Medical Officer Returned to the company · Employee Stock Option (Right to Buy) −107,400 0
2023-12-01 Ticho Barry Chief Medical Officer Grant or award · Restricted Stock Unit (RSU) +60,773 60,773
2023-12-01 Nash Huw M. COO & CBO Returned to the company · Employee Stock Option (Right to Buy) −65,600 0
2023-12-01 Nash Huw M. COO & CBO Grant or award · Restricted Stock Unit (RSU) +8,463 8,463
2023-12-01 Kaye Edward M. MD CEO Returned to the company · Employee Stock Option (Right to Buy) −200,800 0
2023-12-01 Kaye Edward M. MD CEO Grant or award · Restricted Stock Unit (RSU) +25,908 25,908
2023-12-01 Allan Jonathan General Counsel & Corp Sec Returned to the company · Employee Stock Option (Right to Buy) −65,000 0
2023-12-01 Allan Jonathan General Counsel & Corp Sec Returned to the company · Employee Stock Option (Right to Buy) −121,100 0
2023-12-01 Allan Jonathan General Counsel & Corp Sec Grant or award · Restricted Stock Unit (RSU) +46,284 46,284

Page 19 of 24 · 461 trades